NEW YORK CITY, NY / ACCESS Newswire / July 25, 2025 / A quiet revolution took place in Washington last week. With the passage ...

Pharvaris is advancing deucrictibant, an oral bradykinin B2-receptor antagonist, in two late-stage trials. Read my analysis ...

SharkNinja, Inc (NYSE: SN), a global product design and technology company, has appointed Howard Nuk as Chief Advanced ...

He talks with his hands and emphasizes his points with catchphrases such as “How about no” or “How about we don’t.” Lutnick ...

As Africa’s environment ministers meet this week in Nairobi, Kenya, for the 20th African Ministerial Conference on the ...